Article
TGFBI R124H mutant allele silencing in granular corneal dystrophy type 2 using topical siRNA delivery.
Journal of controlled release : official journal of the Controlled Release Society - 10 Jun 2025
McLain Andrew, Kowalczyk Amanda, Baran-Rachwalska Paulina, Sutera Flavia Maria, Robertson Louise J, Nielsen Nadia Sukusu, Enghild Jan J, Cobice Diego, Bonelli Filippo, Barbaro Vanessa, Ferrari Stefano, Patterson Benjamin, Moore Luca, Marshall John, Nesbit M Andrew, Moore Tara
Abstract excerpt
In recent years, success has been achieved in treating several eye conditions with oligonucleotide-based therapies. Herein, we outline the experimentation involved in progressing selection and development of a lead therapeutic siRNA for R124H mutation of TGFBI gene which causes Granular Corneal Dystrophy Type 2 (GCD2/Avellino CD). Firstly, a series of siRNA designs, generated by a gene walk across the R124H TGFBI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
